semaglutide linked to cancer Weight-loss drugs may lower risk in people with diabetes, a study suggests GLP-1 drugs may be linked

The average age was 54, and the average body mass index (BMI) was 35.5

Hence, in case of persistent albuminuria and/or uncontrolled metabolic risks (i.e., inadequate glycemic control, hypertension, overweight/obesity) on SGLT2i therapy, GLP-1RAs should be considered as the preferential add-on therapy in T2DM patients with chronic kidney disease

Neuro-Mag Magnesium L-Threonate Why Should I Supplement With Neuro-Mag Magnesium L-Threonate

At ObesityWeek on Sunday, Viking Therapeutics unveiled early data from the first-in-human study of its investigational oral obesity drug VK2735, touting strong weight loss in healthy adults and an encouraging safety profile.

Researchers isolated a hormone called exendin-4 from the lizards venom that can help regulate blood sugar and appetite in humans